Cover Image
市場調查報告書

家族性腺瘤息肉症:全球臨床實驗趨勢

Familial Adenomatous Polyposis Coli Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 339709
出版日期 內容資訊 英文 79 Pages
訂單完成後即時交付
價格
Back to Top
家族性腺瘤息肉症:全球臨床實驗趨勢 Familial Adenomatous Polyposis Coli Global Clinical Trials Review, H2, 2015
出版日期: 2015年08月19日 內容資訊: 英文 79 Pages
簡介

本報告提供家族性腺瘤息肉症臨床實驗相關之最新趨勢分析,提供您各地區的主要國家臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,以及潛力藥劑比較等資訊。

簡介

  • 家族性腺瘤息肉症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:遺傳性疾病治療藥臨床實驗上家族性腺瘤息肉症的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

家族性腺瘤息肉症治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Zeria Pharmaceutical Co Ltd
    • S.L.A. Pharma AG
    • Pfizer Inc.
    • Thetis Pharmaceuticals LLC
    • SignPath Pharma Inc
    • Onxeo SA
    • Merck & Co., Inc.
    • Marina Biotech, Inc.
    • Bayer AG
    • Aptalis Pharma Inc. (Inactive)
  • 有代表性的研究機關·醫院臨床實驗概要
    • 京都府立醫科大學
    • National Cancer Institute
    • Radboud University
    • The Tel Aviv Sourasky Medical Center
    • The University of Texas M. D. Anderson Cancer Center
    • Assistance Publique - Hopitaux de Paris
    • CSIRO Food and Nutritional Sciences
    • Emory University
    • Leiden University Medical Center
    • Mayo Clinic

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2835CTIDB

GlobalData's clinical trial report, "Familial Adenomatous Polyposis Coli Global Clinical Trials Review, H2, 2015" provides an overview of Familial Adenomatous Polyposis Coli clinical trials scenario. This report provides top line data relating to the clinical trials on Familial Adenomatous Polyposis Coli. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Familial Adenomatous Polyposis Coli
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Familial Adenomatous Polyposis Coli to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Familial Adenomatous Polyposis Coli
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Zeria Pharmaceutical Co Ltd
      • Clinical Trial Overview of Zeria Pharmaceutical Co Ltd
      • S.L.A. Pharma AG
      • Clinical Trial Overview of S.L.A. Pharma AG
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Thetis Pharmaceuticals LLC
      • Clinical Trial Overview of Thetis Pharmaceuticals LLC
      • SignPath Pharma Inc
      • Clinical Trial Overview of SignPath Pharma Inc
      • Onxeo SA
      • Clinical Trial Overview of Onxeo SA
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Marina Biotech, Inc.
      • Clinical Trial Overview of Marina Biotech, Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Aptalis Pharma Inc. (Inactive)
      • Clinical Trial Overview of Aptalis Pharma Inc. (Inactive)
    • Clinical Trial Overview of Top Institutes / Government
      • Kyoto Prefectural University of Medicine
      • Clinical Trial Overview of Kyoto Prefectural University of Medicine
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Radboud University
      • Clinical Trial Overview of Radboud University
      • The Tel Aviv Sourasky Medical Center
      • Clinical Trial Overview of The Tel Aviv Sourasky Medical Center
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • CSIRO Food and Nutritional Sciences
      • Clinical Trial Overview of CSIRO Food and Nutritional Sciences
      • Emory University
      • Clinical Trial Overview of Emory University
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Region, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Familial Adenomatous Polyposis Coli to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Familial Adenomatous Polyposis Coli Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by S.L.A. Pharma AG, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Thetis Pharmaceuticals LLC, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by SignPath Pharma Inc, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Onxeo SA, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Marina Biotech, Inc., 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Aptalis Pharma Inc. (Inactive), 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by The Tel Aviv Sourasky Medical Center, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by CSIRO Food and Nutritional Sciences, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*

List of Figures

  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Familial Adenomatous Polyposis Coli to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Familial Adenomatous Polyposis Coli Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Familial Adenomatous Polyposis Coli Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top